GrantID: 11113
Grant Funding Amount Low: $800,000
Deadline: Ongoing
Grant Amount High: $800,000
Summary
This grant is open to U.S. and international researchers directed towards Alzheimer’s and related dementias. Applications accepted from academic investigators and small companies with lead candidate therapeutic agents that require early stage testing or that have already established human safety data and require a small-scale pilot Proof of Mechanism (POM) study in humans.
To find more grants, go to The Grant Portal and use the Search Grant tool to find your next grant.
Eligible Regions
Interests
Eligible Requirements